Sanofi SA
(NAS:SNY)
$
54.93
0.07 (0.13%)
Market Cap: 137.72 Bil
Enterprise Value: 156.49 Bil
PE Ratio: 30.01
PB Ratio: 1.74
GF Score: 89/100 Sanofi SA at Leerink Partners Global Biopharma Conference Transcript
Mar 12, 2024 / 02:40PM GMT
Release Date Price:
$48.46
(+0.23%)
David Reed Risinger
Leerink Partners LLC, Research Division - Senior MD & Senior Research Analyst
All right. Good morning, everyone. So my name is Dave Risinger. I cover diversified biopharmaceuticals for Leerink Partners, and it's very much my pleasure to welcome you to this session with Sanofi. And I am pleased that we're able to be joined by the 2 key leaders of the Immunology franchise at the company. So Shaju Backer to my immediate left, is the Global Head of the Immunology franchise; Naimish Patel is the Global Head of Development for Immunology and Inflammation. And so thank you both for being with us today.
Questions & Answers
David Reed Risinger
Leerink Partners LLC, Research Division - Senior MD & Senior Research Analyst
And it's actually great timing on the heels of AAD. And so I thought maybe you could start with just some comments on the momentum for the company and quick takeaways from AAD.
Shaju Backer
Sanofi - Global Head of Immunology Franchise
Sure. So Naimish, I might talk
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot